• Home
  • Industry News
  • GSK Announces EU Regulatory Submission of Candidate Vaccine for Prevention of Shingles

GSK Announces EU Regulatory Submission of Candidate Vaccine for Prevention of Shingles


GlaxoSmithKlineGlaxoSmithKline plc (LSE/NYSE: GSK) has announced the regulatory submission of a Marketing Authorisation Application (MAA) to the European Medicines Agency (EMA) seeking approval for its candidate shingles vaccine, ShingrixTM, for the prevention of herpes zoster (shingles) in people aged 50 years or over.

Source link